Evidence map›Paper›PMID 33883043›Full record

ArticleBiomaterials research2021

Biosilicated collagen/β-tricalcium phosphate composites as a BMP-2-delivering bone-graft substitute for accelerated craniofacial bone regeneration.

Dong Keon Lee, Mi-Ran Ki, Euy Hyun Kim, Chang-Joo Park, Jae Jun Ryu, Hyon Seok Jang, Seung Pil Pack, Yun Kee Jo, Sang Ho Jun

Open access · goldAbstract read
In one paragraph

Article in Biomaterials research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Application of collagen in bone regeneration.Journal of orthopaedic translation · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Biomineral-Based Composite Materials in Regenerative Medicine.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Dong Keon Lee *Department of Oral and Maxillofacial Surgery, Korea University Anam Hospital, 02841, Seoul, Korea.
Mi-Ran Ki *Department of Biotechnology and Bioinformatics, Korea University, 30019, Sejong, Korea.
Euy Hyun KimDepartment of Oral and Maxillofacial Surgery, Korea University Anam Hospital, 02841, Seoul, Korea.
Chang-Joo ParkDivision of Oral and Maxillofacial Surgery, Department of Dentistry, College of Medicine, Hanyang University, 04763, Seoul, Korea.
Jae Jun RyuDepartment of Prosthodontics, Korea University Anam Hospital, 02841, Seoul, Korea.
Hyon Seok JangDepartment of Oral and Maxillofacial Surgery, Korea University Ansan Hospital, 15355, Ansan, Korea.
Seung Pil PackDepartment of Biotechnology and Bioinformatics, Korea University, 30019, Sejong, Korea. spack@korea.ac.kr.
Yun Kee JoDepartment of Biomedical Convergence Science and Technology, School of Convergence, Kyungpook National University, 41566, Daegu, Korea. ykjo@knu.ac.kr.
Sang Ho JunDepartment of Oral and Maxillofacial Surgery, Korea University Anam Hospital, 02841, Seoul, Korea. junsang@korea.ac.kr.
Korea University · KRAnsan University · KRHanyang University · KRKyungpook National University · KR

Funding

National Research Foundation of Korea NRF-2020R1A2C2009296National Research Foundation of Korea NRF-2021R1C1C1008560
6 · The paper itself

Abstract

backgroundBioceramic β-tricalcium phosphate (β-TCP) is used as a bone-grafting material and a therapeutic drug carrier for treatment of bone defects in the oral and maxillofacial regions due to the osteoconductivity and biocompatibility. However, the low mechanical strength and limited osteoinductivity of β-TCP agglomerate restrict bone regenerating performance in clinical settings.

methodsHerein, a biomimetic composite is proposed as a bone morphogenetic protein-2 (BMP-2)-delivering bone graft substitute to achieve a robust bone grafting and augmented bone regeneration.

resultsThe sequential processes of brown algae-inspired biosilicification and collagen coating on the surface of β-TCP enable the effective incorporation of BMP-2 into the coating layer without losing its bioactivity. The sustained delivery of BMP-2 from the biosilicated collagen and β-TCP composites promoted in vitro osteogenic behaviors of pre-osteoblasts and remarkedly accelerated in vivo bone regeneration within a rat calvarial bone defect.

conclusionsOur multicomposite bone substitutes can be practically applied to improve bone tissue growth in bone grafting applications with further expansion to general bone tissue engineering.

Indexed as

Biomimetic materialsBiosilicificationBone morphogenetic protein-2 (BMP-2)Collagen/β-TCP compositeOsteoinductive bone substitute

Identifiers

PMID33883043
PMCPMC8059180
OpenAlexW3153310966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.